ALCOA CRO
Considering the importance and increasing potential of clinical research, the idea of providing services and working in the field of clinical research emerged in 2022.
Feasibility and project planning processes were completed in 2023, with the coming together of experienced and competent names in the pharmaceutical industry and clinical research.
ALCOA, as the face of the healthcare group of companies operating in various fields of the healthcare industry since 1998, opening up to the world of clinical research, will be based in Istanbul in 2024. Dr. It was founded by Hakan Kaptanoğulları.
Our founder, Expert. Dr. ALCOA, built on the vision and values of Hakan Kaptanoğulları, has been encouraging our employees, managers and our organization to be exemplary business leaders in every sense since its establishment.
As ALCOA, we are determined to conduct all our business in accordance with the law, to act honestly, transparently, impartially, ethically and professionally towards our colleagues, customers, suppliers and all business partners, and to protect the reputation and reliability of the ALCOA name.
Our Vision
To become a global player in clinical research by adhering unwaveringly to ethical, quality and performance standards.
We aim to advance healthcare standards, improve patient outcomes and create a benchmark for excellence in the industry through innovation, transparency and collaboration.
Our Mission
We strive for innovative research organization and operation with transparency, excellence and a patient-centered approach.
We provide high-quality and ethical research services that contribute to the advancement of medical knowledge and the development of innovative healthcare solutions.
By supporting compliance standards with a focus on collaboration and prioritizing patient safety, we strive to make meaningful contributions to improving global health outcomes.
